More recently, synovial macrophages from RA patients revealed two subpopulations (MerTK+TREM2+ and MerTK+LYVE1+) with unique remission transcriptomic signatures enriched in negative regulators of inflammation [39]. This evidence concerns the gene MERTK and rheumatoid arthritis.